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Abstract
Background: RNA interference (RNAi) screens have been used to identify novel components of signal-transduction
pathways in a variety of organisms. We performed a small interfering (si)RNA screen for novel members of the
transforming growth factor (TGF)-b pathway in a human keratinocyte cell line. The TGF-b pathway is integral to
mammalian cell proliferation and survival, and aberrant TGF-b responses have been strongly implicated in cancer.
Results: We assayed how strongly single siRNAs targeting each of 6,000 genes affect the nuclear translocation of a
green fluorescent protein (GFP)-SMAD2 reporter fusion protein. Surprisingly, we found no novel TGF-b pathway
members, but we did find dominant off-target effects. All siRNA hits, whatever their intended direct target, reduced
the mRNA levels of two known upstream pathway components, the TGF-b receptors 1 and 2 (TGFBR1 and TGFBR2),
via micro (mi)RNA-like off-target effects. The scale of these off-target effects was remarkable, with at least 1% of the
sequences in the unbiased siRNA library having measurable off-target effects on one of these two genes. It seems
that relatively minor reductions of message levels via off-target effects can have dominant effects on an assay, if
the pathway output is very dose-sensitive to levels of particular pathway components. In search of mechanistic
details, we identified multiple miRNA-like sequence characteristics that correlated with the off-target effects. Based
on these results, we identified miR-20a, miR-34a and miR-373 as miRNAs that inhibit TGFBR2 expression.
Conclusions: Our findings point to potential improvements for miRNA/siRNA target prediction methods, and
suggest that the type II TGF-b receptor is regulated by multiple miRNAs. We also conclude that the risk of
obtaining misleading results in siRNA screens using large libraries with single-assay readout is substantial. Control
and rescue experiments are essential in the interpretation of such screens, and improvements to the methods to
reduce or predict RNAi off-target effects would be beneficial.
Background
RNA interference (RNAi) has emerged as a central tool
to analyze the function of mammalian genes, both
in vitro and in vivo. The technology has been widely
used in mammalian cells to suppress the expression
level of individual genes, thus helping to define the
functional roles of genes, particularly in disease. RNAi
screens, using either double-stranded RNA in Droso-
phila cells, or small hairpin (sh)RNA or small interfering
(si)RNA libraries in mammalian cells, have been used
for the identification of novel components of a variety
of signal-transduction pathways [1]. Large-scale siRNA
screens in mammalian cells have been performed to
identify modulators of the cell cycle [2], nuclear factor-
B signaling [3] and b-catenin signaling [4], and also in
the study of infectious diseases [5-10] and in stem cells
[11,12]. Much work has centered around siRNA design
algorithms, with a focus on gene-target specificity and
efficiency [13-17]. However, individual siRNAs have
been shown to downregulate tens or even hundreds of
genes by binding in a micro (mi)RNA-like manner to
the 3’ untranslated regions (UTRs) of off-target mRNAs
[18-22]. Screens attempt in a number of ways to control
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Transforming growth factor (TGF)-b is part of a large
metazoan family of multifunctional cytokines involved
in a wide range of cellular processes, including prolifera-
tion, apoptosis, differentiation and migration. Although
its functions are diverse, TGF-b is the archetypal anti-
mitogenic cytokine, affecting a wide variety of epithelial
and endothelial cells, and involving widely divergent
cellular processes, such as cytostasis, apoptosis and
induction of cellular senescence [24]. As part of a sig-
nal-transduction pathway integral to mammalian cell
proliferation and survival, aberrant TGF-b responses
have been strongly implicated in neoplastic development
[25,26]. The loss of the cytostatic response to TGF-b,
coupled with retention of TGF-b signaling components,
results in the in vivo selection of more aggressive
tumors [27]. In the absence of the cytostatic program,
TGF-b promotes increased invasive capability as a result
of induced epithelial-mesenchymal transdifferentiation
[28]. TGF-b signaling is mediated by a short cascade:
binding of TGF-b to a type II TGF-b receptor
(TGFBR2) leads to recruitment and phosphorylation of
a type I receptor (TGFBR1), which can then phosphory-
late the transcription factors SMAD2 and SMAD3.
Phosphorylated SMADs accumulate in the nucleus,
where they form complexes with SMAD4 and other
transcriptional regulators, and activate or repress the
transcription of many target genes [24]. Modulation of
cell responsiveness to TGF-b can theoretically occur at
any of the several steps of the signaling pathway from
the membrane to gene-promoter regions, and mutations
of several of the integral pathway components have
been characterized in certain cancers [29-31]. However,
only the two TGF-b receptors TGFBR1 and TGFBR2
have thus far been shown to be essential, non-redundant
pathway components required for SMAD phosphoryla-
tion and subsequent nuclear translocation.
To identify novel components and modulators of the
TGF-b pathway, we performed a large-scale (6,000-
gene) functional RNAi screen for genes affecting TGF-
b-induced nuclear translocation of a green fluorescent
protein (GFP)-SMAD2 fusion protein in human kerati-
nocytes (HaCaT). We identified and validated 176 siR-
NAs that negatively regulate GFP-SMAD2 nuclear
localization in response to TGF-b. Further analysis of
these siRNAs revealed a common mechanism of influ-
ence on TGF-b signal transduction through miRNA-like
off-target effects on TGFBR1 and TGFBR2. In particular,
TGFBR2 was the more frequent target of silencing, and
an unexpectedly large number of siRNAs targeted both
receptors.
We investigated the relationship between sequence
complementarity of the target site, the number of sites
and the screen ranking to determine the rules for this
miRNA-like targeting. Our results validate rules recently
identified by others, and we provide further evidence for
the importance of sequence complementarity outside of
the siRNA seed region.
Results
A 6,000-gene siRNA screen to look for TGF-b pathway
components
The screen used a nuclear translocation assay consisting
of a GFP-SMAD2 fusion protein stably expressed in
HaCaT keratinocytes (Figure 1A) [32]. Translocation of
this reporter from the cytoplasm to the nucleus can be
tracked and quantified by fluorescence microscopy.
Using a 384-well format, we transfected our assay cell
line with a 6,000-gene siRNA library consisting of multi-
ple independent siRNAs targeting each gene (total of
21,000 siRNAs) (Figure 1B). Positive (siRNAs targeting
TGFBR2) and negative (non-targeting siRNAs) transfec-
tion controls were included on every plate. Two days
after transfection, cells were stimulated with TGF-b, and
the nuclear translocation of SMAD2 was quantified
using the mean nuclear:cytosolic (N:C) localization ratio
of GFP-SMAD2. This ratio was assessed by automated
confocal microscopy using GFP intensities from an aver-
age of 220 cells per well. A higher N:C ratio (> 1.1) indi-
cates nuclear localization, whereas a lower N:C ratio (<
1.1) is indicative of a predominantly cytosolic localiza-
tion. An siRNA causing a significant deviation (positive
or negative) of the N:C ratio from the mean is expected
to have affected a gene involved in the TGF-b pathway.
A change in the N:C ratio can be caused by facilitation
or inhibition of TGF-b-induced GFP-SMAD2 phosphor-
ylation or nuclear translocation.
We found a correlation between cell density and N:C
ratio, and normalized for this effect (see Methods). This
normalization procedure had a large effect on N:C ratios
for the siRNAs that caused an increase in N:C ratio, but
only a small effect on the siRNAs that caused a decrease
in N:C ratio (see Additional File 1 Figure S1; for full
screening results, see Additional File 2 Table S1;
selected representative images are available at http://
cbio.mskcc.org/tgf-beta_screen/).
A number of siRNAs caused a significant change in nuclear
localization of GFP-SMAD2
Using normalized N:C ratios, we found that 136 siRNAs
caused a significant decrease, and 43 a significant
increase, in nuclear translocation relative to the mean
when stimulated with TGF-b (using a cut-off of 2.5
standard deviations (SDs)) (Figure 1C). The siRNAs that
caused an increase in N:C ratio were predominantly
affected by large variations in cell density. We per-
formed experimental validation on the four siRNAs that
caused the greatest increase, but could not reproduce
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that most of these siRNAs were false positives caused by
the sensitivity of the assay to changes in cell density,
and we focused all subsequent analyses on those siRNAs
that caused a decrease in N:C ratio, because these were
much less affected by variations in cell density.
Effects of screen hits were reproducible
The siRNA hits resulting in the greatest decrease in the
N:C ratios of GFP-SMAD2 were tested for effects on
translocation of endogenous SMAD2 in response to
TGF-b (data not shown). Initial analysis of a subset of
high-ranking siRNA hits identified effects on SMAD2
phosphorylation and TGF-b-dependent gene transcrip-
tion (Figure 2). Transfection of hit siRNA compared
with control (LacZ siRNA) resulted in decreased TGF-
b-dependent SMAD2 phosphorylation (as determined by
immunoblot analysis) and a decrease in nuclear SMAD2
in response to TGF-b treatment (Figure 2A). Total
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Figure 1 Results of a 6,000 gene small interfering (si)RNA screen using a green fluorescent protein (GFP)-SMAD2 translocation assay.
(A) GFP-SMAD2 translocation assay in the context of the transforming growth factor (TGF)-b pathway. (B) Screen timeline. (C) Distribution of
normalized nuclear:cytosolic (N:C) ratios for all siRNAs used in the screen. Screen ‘hits’ show increased or decreased GFP-SMAD2 nuclear
translocation relative to the mean after TGF-b stimulation. The N:C ratio was determined by image analysis of an average of 220 cells per well.
Group 1 comprised 134 small interfering (si)RNAs that led to a decrease in GFP-SMAD2 translocation (s > 2.5), whereas group 2 comprised 42
siRNAs that led to an increase in GFP-SMAD2 translocation (s > 2.5).
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fected (data not shown). Induction of endogenous TGF-
b target genes p21 (CDKN1A), SMAD7 and PAI-1 (SER-
PINE1) was decreased in cells transfected with siRNA
hits relative to control (Figure 2B). The tested siRNA
hits were also effective at reducing mRNA levels of tar-
geted genes (measured by quantitative (q)PCR) (see
Additional File 2 Table S2).
siRNA target genes were not responsible for the screen
phenotype
After validating the effects of selected hit siRNA on
TGF-b signaling, we next tried to identify candidate
genes for further validation and characterization.
Attempts to group the genes with siRNA hits by func-
tion (based on Gene Ontology and signaling pathway
data) did not reveal any over-represented biological pro-
cesses or signaling pathways, nor was there a significant
number of genes previously associated with members of
the TGF-b pathway in large-scale protein-protein inter-
action screens [33-35].
Furthermore, of the ~6,000 genes represented by two
to five independent siRNAs, there were no multiple
siRNA hits for the same gene. One possible explanation
for this is that the library had a low knockdown effi-
ciency in HaCaT cells. Tests of eight sets of three siR-
NAs designed to target a specific gene found that the
ratio of potent siRNAs per gene was somewhat variable,
with only one potent siRNA for each of the genes in
some cases, and several potent siRNAs in others (data
not shown). This confirmedt h er e s u l t so ft e s t sp e r -
formed during the design phase of the library (see
Methods) [17], and suggested that only one or two out
of three siRNAs per gene could be expected to lead to a
potent (> 50%) knockdown. Of 24 tested siRNA hits
whose targets were expressed in HaCaT cells, the siR-
NAs identified as hits were effective in reducing the
mRNA levels of their intended targets (see Additional
File 2 Table S2). However, more than 20% of the siRNA
hits were found to be against gene targets not expressed
in HaCaT cells (the assay cell line).
The possibility that the siRNA effect was mediated by
something other than the intended target gene (for
example, through off-target effects on genes involved in
the pathway) was supported by two independent obser-
vations. Firstly, the effects on TGF-b signal transduction
or receptor mRNAs were not seen using independent,
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Figure 2 Effects of small interfering (si)RNA hits on transforming growth factor (TGF)-b signaling validated by various methods. (A)
Immunodetection of receptor-phosphorylated SMAD2 in extracts of HaCaT cells transfected with the indicated siRNAs and treated with 100
pmol/l TGF-b for 30 minutes. Numbers represent ranked siRNA hits. (B) Effect of siRNA hits on TGF-b-mediated induction of endogenous gene
responses. HaCaT cells were incubated with or without 100 pmol/l TGF-b for 3 hours before harvest. Quantitative PCR analysis was used to
determine changes of mRNA levels of indicated genes. The mean ± SD of three experiments is shown. Integers (for example, 1, 19) label ranked
siRNA hits.
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of the selected targets. Secondly, specific chemical inhi-
bition (where applicable) of the siRNA target gene pro-
tein products had no effect on TGF-b-mediated gene
induction (see Additional File 1 Figure S2).
Off-target effects on TGF-b receptor mRNAs dominate
screen hits
TGF-b receptor levels were altered by all screen hits
We saw early evidence that the two most likely candidates
for off-target effects were the TGF-b receptors, TGFBR1
and TGFBR2. Transfection of some of the top-ranked
siRNA hits resulted in significant reduction in mRNA
levels of the known TGF-b pathway components TGFBR1
and TGFBR2 (Table 1; see Additional File 2 Table S3).
This prompted us to systematically test the other siRNA
hits for effects on TGF-b receptor mRNA levels using
qPCR or a branched DNA assay. We tested the top 134
siRNAs that had caused a translocation effect with an SD
s < 2.5, an additional 44 siRNAs that had an effect with a
SD of 2.0<s < 2.5 and 15 siRNAs that had received posi-
tive scores in a previous small validation screen.
Of these 193 tested siRNA hits (remember that all
were designed to reduce expression of their respective
target genes), 172 caused an off-target reduction (>
25%) of mRNA levels of at least one of the TGF-b
receptors: 21 had an effect on TGFBR1 only, 109 had an
effect on TGFBR 2 only, and 42 had effects on both
simultaneously to varying degrees (Table 1). For the
remaining 21 siRNAs without off-target effects on either
TGFBR1 or TGFBR2 mRNAs, there was no detectable
effect on TGF-b signaling as measured by the induction
of transcription of selected TGF-b target genes
(SMAD7, CDKN1A, SERPINE1) and phosphorylation of
SMAD2 (data not shown). These hits are probably a
result of noise in the assay system, and we defined these
s i R N A sw i t h o u ta ne f f e c to nT G F - b signaling as false
positives, giving a rate of 5% false positives for our
screen for siRNA with s > 2.5.
Luciferase assay confirmed that the screen siRNA hits act
on the TGFBR2 3’ UTR
Off-target effects have been shown to be mediated by
partial complementarity between siRNAs and the 3’
UTRs of off-target genes [18-22]. To verify the mechan-
ism of the off-target effects seen in our screen, we tested
the effects of selected siRNA hits on the 3’ UTR of the
TGFBR2. We used a luciferase reporter assay in which
the mRNA for firefly luciferase was fused to the 3’ UTR
region or the open reading frame (ORF) for TGFBR2,
and expressed from a constitutive promoter (Figure 3).
Of 13 siRNA hits tested, 11 selectively decreased the
activity translated from the luciferase transcript fused to
the 3’ UTR of TGFBR2 (Figure 3). A few siRNAs were
also seen to affect the luciferase reporter fused to the
ORF, albeit to a much lesser extent. These data confirm
the ability of the siRNA hits to mediate the silencing of
mRNAs containing the 3’ UTR of TGFBR2. By contrast,
siRNA non-hits (corresponding to the same genes as the
siRNA hits) were not able to silence luciferase tran-
scripts containing the 3’ UTR of TGFBR2 in this system
(see Additional File 1 Figure S3).
These results indicate that the HaCaT GFP-SMAD2
translocation system is a useful tool for screening modu-
lators of the TGF-b pathway, as modulation of GFP-
SMAD2 translocation correlated well with effects on
gene expression of members of the TGF-b pathway, and
could be detected and measured with a low rate of false
positives. However, interestingly, all siRNAs scoring as
hits in the GFP-SMAD2 translocation system had off-
target effects on the mRNAs of just two of the known
components of the TGF-b pathway. These off-target
effects on the receptors immediately explain the effect
of these siRNAs in the screen, as SMAD2 is directly
downstream of the TGF-b receptors. Thus, contrary to
our original intent, we were not able to identify any pre-
viously unidentified pathway components using this
screen.
Off-target effects are mediated by miRNA-like target sites
Heptamer seed motifs in TGFBR2 are enriched in screen hits
Off-target effects reported in previous RNAi studies
were mediated by partial complementarity between siR-
NAs and the 3’ UTRs of off-target genes, involving a
heptamer or hexamer ‘seed’ match of the siRNA strand
at the 5’ end at positions 2 to 8 or 2 to 7, respectively
[18-22]. The mechanism is similar to that of miRNAs,
and multiple sequence elements have been proposed to
play important roles (Figure 4).
Sequence analysis of all siRNAs used in our screen
showed that, compared with siRNA non-hits, a signifi-
cantly larger percentage of high-ranking siRNAs had
heptamer seed matches of the siRNA guide strand
against the 3’ UTR of TGFBR2 (Figure 5A). This
Table 1 Repression of TGFBR1 and TGFBR2 mRNAs by the
193 tested screen siRNA
a hits
b
Off-target mRNAs affected Number of siRNAs
TGFBR1 only 21
c
TGFBR2 only 109
Both TGFBR1 and TGFBR2 42
No off-target effect (false positives) 21
asiRNA = small interfering RNA.
bScreen hits were grouped by their effects on mRNA levels of TGFBR1 and
TGFBR2, as determined by branched DNA assay (most siRNA) or quantitative
(q)PCR (some siRNA).
cFor the 21 siRNAs without off-target effects, the effects on TGF-b signaling
were not verifiable by phospho-SMAD2 western blots or by qPCR of
characteristic TGF-b target gene mRNAs (false positives) (see Additional File 2
Table S3 for detailed expression data).
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Page 5 of 20percentage dropped rapidly as a function of the screen
rank, with a steep decline in the first 200 ranks, followed
by a slower decline to a steady level at around rank
2,500. This suggests that there are weak hits in the top
2,500 siRNAs, but the percentage of verifiable hits is
m u c hl o w e rt h a ni nt h et o p2 0 0 .Ac o m p a r i s o no f
siRNA seed sequence matches with the 3’ UTRs of all
RefSeq genes in the top 200 siRNA screen hits and non-
hits identified TGFBR2 as the most significantly (off-)
targeted gene (see Additional File 3 Table S4), by a wide
margin (adjusted p-value = 6.42*10
-12). A similar analy-
sis using the passenger-strand sequences identified
TGFBR2 in the top 10 most strongly targeted genes (p-
value not significant, see Additional File 3 Table S5),
and when sequence data from both strands were com-
bined, TGFBR2 was the only significantly targeted gene
(adjusted p-value = 1.22*10
-11, see Additional File 3
Table S6).
There was no apparent enrichment for seed matches
against the TGFBR1 3’ UTR when the top 200 hits were
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Figure 3 Confirmation that screen small interfering (si)RNA hits acted primarily on the 3’ untranslated region (UTR) of the
transforming growth factor-b receptor 2 (TGFBR2) mRNA. Silencing of luciferase-TGFBR2 3’ UTR or luciferase TGFBR2 open reading frame
(ORF) protein expression by four representative siRNA hits. Two independent siRNAs were used as non-targeting controls (controls 1 and 2), and
a microRNA miR-20a mimic and an siRNA with perfect complementarity to the TGFBR2 ORF were used as positive controls for the 3’ UTR and
the ORF constructs, respectively. The data are reported (y-axis) as the relative repression of firefly luciferase expression standardized to Renilla
luciferase as a transfection control. Integers (for example, 9, 18) label ranked siRNA hits. Error bars on each column are the mean ± SD of three
experiments.
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Figure 4 On-target and off-target mechanisms of small interfering (si)RNAs. All siRNAs were designed to have perfect complementarity
between the siRNA guide strand and the open reading frame (ORF) of the target gene. Off-target effects were mediated primarily through
partial complementarity with the 3’ untranslated region (UTR) of off-target genes. Complementarity of the siRNA seed (positions 2 to 8), possibly
containing G:U wobbles, was thought to be the key determinant Additional known features were the occurrence of an A in the mRNA opposite
position 1 of the siRNA (t1A), and partial pairing between the 3’ end of the siRNA and the mRNA.
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this enrichment was simply masked by the much larger
number of siRNAs targeting TGFBR2. Subdividing the
verified siRNA hits into TGFBR1 and TGFBR2 hits
based on our mRNA expression data (see Additional
File 2 Table S3) revealed an enrichment of seed matches
against the TGFBR1 3’ UTR of the siRNAs that targeted
TGFBR1 (Figure 5B). For this analysis, only siRNAs
causing a knockdown of ≥40% were considered (43 siR-
NAs with an effect on TGFBR1 and 106 with an effect
on TGFBR2; siRNAs with effects on both receptors were
included in both lists). The list of 106 siRNAs with an
effect on TGFBR2 was used for all further analyses.
These 106 siRNAs contained 92 unique seven-mer seed
sequences. For the non-hit control group, we used siR-
NAs ranked between 12,001 and 17,000 (Figure 5A).
The off-target effects we found seem to be overwhel-
mingly mediated by the guide strand of the siRNA, as
suggested by the significant enrichment of guide-strand
seed matches against the 3’ UTR of TGFBR1 and
TGFBR2 in the siRNA hit group (Figure 5B). However,
there was also a smaller but significant enrichment of
seed matches in the passenger strand of the siRNA hits,
indicating that in some cases the strand designated as
the siRNA passenger strand has silencing activity. The
preferred incorporation of the guide strand into the
RNA-induced silencing complex (RISC) was by design,
as the library contains a bias for sequence-directed
strand insertion into the RISC [36].
We did not detect enrichment of target sites in the 5’
UTR of either TGFBR1 or TGFBR2.T h e r ew a so n l ya
small enrichment of borderline significance in the ORF
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Figure 5 Sequence signal for off-target effects: small interfering (si)RNA seed matches against the 3’ untranslated region (UTR) of
transforming growth factor-b receptor 2 (TGFBR2) decreased with rank in the screen. The effects were predominantly mediated by the
guide strand, and hexamer seed matches were not effective. (A) Moving average of the percentage of siRNA guide strand seed matched to the
3’ UTR of the receptors as a function of siRNA rank in the screen (window: 500). (B) Off-target effects against transforming growth factor-b
receptor 1 (TGFBR1) and TGFBR2 were mediated predominantly by 3’ UTR matches of the siRNA guide strand, but to a small extent by the
passenger strand. Enrichment of heptamer seed matches of the guide and passenger siRNA strands to TGFBR1 (left) and TGFBR2 (right) 3’ UTRs
are shown for siRNAs with a confirmed effect on TGFBR1 and TGFBR2. (C) Heptamer, not hexamer, seed matches were responsible for TGFBR2
silencing. When we analyzed only for the presence of hexamer seed matches that were not part of a heptamer match, there was no enrichment
in the TGFBR2 hit siRNA compared with control siRNA.
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match to the TGFBR2 3’ UTR, the signal became signifi-
cant (see Additional File 1 Figure S4).
Both hexamer and heptamer seed matches have pre-
viously been attributed to siRNA off-target effects [19].
However, we found that in our data, true hexamer
matches (that is, those hexamer matches that were not
part of a heptamer match), were not enriched in the hits
against TGFBR2 compared with non-hits (Figure 5C).
We reanalyzed the data by Birmingham et al. [19], and
noted that the enrichment of hexamer matches reported
can be explained exclusively by those hexamer matches
that are part of a heptamer match (data not shown).
Others have found only a very small contribution of true
hexamer seed matches to siRNA off-target effects [37].
The identification of a heptamer sequence base-pairing
between siRNAs and target mRNA as part of a mechan-
ism for off-target effects in our screen is supported by
several independent studies [18-22,37,38]. However, as
with other studies, ‘enrichment’ of this complementarity
motif alone is not enough to explain the hits.
Heptamer seed motifs grossly overpredict hits
One challenge lies in the understanding why so many of
our siRNAs with perfect seed matches to the ORF and
3’ UTR of both receptors did not emerge as hits in the
assay. Seed-match analysis predicted more than 3,000 of
the 20,000 siRNAs in the screen to have potential off-
target effects on the 3’ UTR of the TGFBR2 mRNA
alone, yet only a fraction seemed to be actually effective
(Figure 6). Although additional sequence characteristics
have been reported [37,38], the price of increased
enrichment is typically the identification of many more
false negatives. Some groups have attempted to use
mRNA secondary structure and site accessibility to aid
prediction, with limited success to date [39,40].
Why do siRNAs with identical ‘seeds’ cause different
outcomes in the assay? Evidence suggests three possible
reasons: 1) sequence differences outside of the seed that
alter their ability to silence the off-target mRNA; 2) dif-
ferent siRNAs have different abilities to be efficiently
l o a d e di n t ot h eR I S C ;a n d3 )a s s a yr e s u l tv a r i a t i o na sa
result of technical reasons or biological variability (false
negatives). Using sequence analysis, we found a small
difference in 3’ binding ability (four-mer or five-mer
match of the siRNA between positions 10 and 19)
between the hit and non-siRNA hits with identical seed
sequences. This suggests that differences between these
siRNAs can be at least partly explained by sequence dif-
ferences outside of the seed region. However, experi-
mental testing identified some false negatives with seed
heptamers that were identical to those of some siRNA
hits. We tested five siRNAs with seed sequences identi-
cal to those occurring multiple times within the
TGFBR2 hits, and found that they caused downregula-
tion of TGFBR2 mRNA (qPCR, data not shown).
Identification of other siRNA (off-)target recognition
determinants
In addition to this massive overprediction, more than
40% of our hits did not contain a heptamer motif. Of
the 106 verified hits on TGFBR2, 61 contained heptamer
motifs and 45 did not (Figure 6). Because we are confi-
dent that this assay is affected by a drop in either
TGFBR1 or TGFBR2 expression, we wanted to explore
additional determinants that are not captured simply by
a heptamer match. Theoretically, there are several possi-
ble factors: 1) RISC incorporation of the other siRNA
strand, 2) effects on the ORF, 3) cooperativity between
multiple weaker sites, 4) other match requirements
beyond or instead of positions 2 to 8, and 5)
57.5%
(61 of of 106) 
16.9%
(3203 of
 18928) 
0% 
10% 
20% 
30% 
40% 
50% 
60% 
70% 
80% 
90% 
100% 
1 or more heptamers 
%
 
o
f
 
s
i
R
N
A
 
w
i
t
h
 
s
e
q
u
e
n
c
e
 
m
o
t
i
f
 
 entire library 
motif enrichment
r= 3.4 
61 
3203 
0 
500 
1000 
1500 
2000 
2500 
3000 
3500 
4000 
4500 
1 or more heptamers 
n
u
m
b
e
r
 
o
f
 
s
i
R
N
A
 
w
i
t
h
 
s
e
q
u
e
n
c
e
 
m
o
t
i
f
 
 hits   entire library 
52.5-fold
overprediction 
hits
Figure 6 False prediction of thousands of hits by seed method. Although we found an enrichment of heptamer seed matches to
transforming growth factor-b receptor 2 (TGFBR2) in the hit population (left), only 2% of all small interfering (si)RNAs with heptamer seed
matched scored as hits (right).
Schultz et al. Silence 2011, 2:3
http://www.silencejournal.com/content/2/1/3
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dimensional structure of the mRNA).
We used the list of 106 siRNAs with strong effects on
TGFBR2 to test whether we could confirm previous findings
and find additional sequence motifs (Figure 7, Figure 8).
Conserved regions of the TGFBR2 3’ UTR are preferentially
targeted by siRNA hits
Heptamer motif analysis of screen hits identified distinct
regions of the TGFBR1 and TGFBR2 3’ UTR that
seemed to be preferentially targeted by siRNA hits, sug-
gesting the possibility of RNAi ‘hotspots’ in the 3’ UTR
(Figure 7). These hotspots overlapped with those regions
that are the most highly conserved in vertebrates (Figure
7). Unlike for TGFBR1, The targeted regions of TGFBR2
were also close to the 5’ and 3’ ends of the 3’ UTR, a
phenomenon that has been reported previously for miR-
NAs and their target genes [38,41,42].
However, we found that although siRNAs with heptamer
matches in conserved regions of the TGFBR2 3’ UTR
(threshold of 0.5, phastCons 17 species) were more likely
to silence the TGFBR2 mRNA, only 34 of our verified 106
siRNAs (32% of hits) were now predicted to hit TGFBR2.
This strongly suggests that conservation should be used as
a weighted factor but not as a filter (see Discussion).
siRNAs with multiple target sites are more likely to silence
TGFBR2
We found that siRNAs with multiple heptamer matches
against the TGFBR2 3’ U T Rw e r em o r el i k e l y ,b ya
factor of ~3.0, to silence the TGFBR2 mRNA than siR-
NAs with only one heptamer match (Figure 8A).
Target nucleotides opposite siRNA positions 1 and 9
contribute to off-target effects
Our data also reflected a strong prevalence of an adeno-
sine opposite the first position of the siRNA (Figure 8B).
This has been termed the ‘t1A anchor’ and previously
shown to be an important parameter for miRNA target
specificity [43]. In addition, we found a previously
d e s c r i b e dp r e v a l e n c e[ 3 7 ]o fAo rUa tp o s i t i o n9 ,a d j a -
cent to the seed (Figure 8C).
Matches of the siRNA 3’ end, particularly position 16,
increase off-target effects on TGFBR2
We analyzed the data for the involvement of base pair-
ing between the 3’ half of the siRNA guide strand and
the TGFBR2 mRNA. Of the siRNAs with heptamer seed
matches, we detected enrichment in 3’ pairing of three
or four bases (between positions 12 and 19 with an off-
set of no more than two nucleotides) in the TGFBR2
siRNA hits compared with siRNA non-hits (Figure 8D).
The combination of multiple sequence motifs further
increased this enrichment: siRNA hits with all three cri-
teria (a heptamer seed match, a t1A match and with 3’
pairing) seemed to be most potent, but only 2.5% of all
TGFBR2 siRNA hits fulfilled these criteria (Figure 8D).
Performing an analysis of matches in each position
revealed a significant enrichment of complementarity at
position 16 of the siRNA hits (Figure 8D). These
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tary flanking sequence (of the 28 siRNAs with the posi-
tion 16 match, only eight had an additional flanking
match at position 17 or 18, but the 20 matches were
isolated). A special significance of position 16 for siRNA
targeting efficiency has been reported previously [22],
and microarray data of siRNA-transfected cells by Jack-
son et al., although not discussed in their publication,
also showed a correlation between matches at position
16 and off-target effects [20].
We did not observe the position 16 effect in a set of
11 different previously published miRNA transfection
experiments in HeLa cells [38,44]. Messenger RNAs
with a seed match (seven-mer) in combination with a
position 16 match were slightly more repressed after
miRNA transfection compared with mRNAs with seed
matches alone, but the extent of this effect was not sig-
nificant (P < 0.2, Wilcoxon rank sum test).
G:U wobbles in the siRNA 5’ end can contribute to off-
target effects
Imperfect seed matches containing G:U wobbles have
been shown to be functional in several examples of miR-
NAs and their target genes [45,46], but several studies
have found G:U wobbles to interfere negatively with
miRNA activity [47,48]. G:U wobbles were not pre-
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including G:U wobbles was found to be far below that
of perfect seed matches [43]. In our results, we found
an over-representation of G and U nucleotides in the
seed regions of siRNA hits, specifically U bases at posi-
tions 2, 4, 5 and 7, and G bases at positions 3 and 6
(Figure 9A), suggesting that some siRNAs may be able
to exert their silencing effects through imperfect seed
matches containing G:U wobble base pairs.
Allowing for one G:U wobble base-pair of the guide
strand with the TGFBR2 t r a n s c r i p t ,w i t haUa t
positions 2, 4, 5 or 7 of the siRNA guide strand, we
found a small but significant enrichment of seed
matches to the TGFBR2 3’ UTR in the hit versus the
non-hit population. The G:U wobbles seemed to occur
in specific positions and orientations: positions 2 and 4
(U in the siRNA) and positions 3 and 8 (G in the
siRNA) (Figure 9B).
TGFBR2 as a potential miRNA target
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Page 11 of 20hits suggests the possibility of RNAi ‘hotspots’ in the 3’
UTR, that is, UTR regions particularly accessible to
regulation by small RNAs, including expressed miR-
NAs (Figure 7A). These regions tend to be highly con-
served across vertebrate genomes (Figure 7B), and
contain predicted target sites for miRNAs. We there-
fore went beyond the siRNA screen and looked for evi-
dence for repression of TGFBR2 by expressed miRNAs
(in HaCaT cells), such as miR-20a, miR-93, miR-34a
and miR-423, and non-expressed miRNAs, such as
miR-373.
Two of the miRNAs predicted to have target sites in
these regions are miR-20a (which has been shown to tar-
get TGFBR2 in megakaryocytes [49]) and miR-34a. Both
these miRNAs were also expressed in the HaCaT cells
used in this study (tested by microarray and Taqman
qPCR). The fact that TGFBR2 is expressed in HaCaT cells
despite the presence of these mRNAs raises the question
of the strength of regulation of TGFBR2 expression, if any,
by these miRNAs in this cell line. In transfection experi-
ments using miRNA mimics and inhibitors, we found that
TGFBR2 is indeed regulated by miR-20a and miR-34a in
HaCaT cells. Luciferase activity of a construct containing
the TGFBR2 3’ UTR luciferase transcript and TGFBR2
mRNA levels were significantly reduced by transfected
miR-20a or miR-34a (Figure 10A), and transfection of
miR-20a or miR-34a inhibitors caused an increase in the
TGFBR2 mRNA level (Figure 10B).
These examples suggest that the TGFBR2 mRNA is
under the control of expressed miRNAs, and that
changes in the expression levels of these miRNAs can
modulate the expression level of the receptor. Inhibition
of miR-20a or miR-34a leads to increased levels of
TGFBR2 mRNA, whereas addition of exogenous miR-
20a or miR34a leads to drastically reduced levels of
TGFBR2 mRNA.
To probe the susceptibility of TGFBR2 to repression
by non-expressed miRNAs, we tested two mimics of
miRNAs not expressed in HaCaT cells: miR-373, which
is predicted to target TGFBR2,a n dm i R - 3 4 b ,w h i c hi s
predicted not to target TGFBR2. Transfection of miR-
373 did cause a decrease in TGFBR2 mRNA levels (Fig-
u r e1 0 A ) ,b u tc o n s i s t e n tw i t ht a r g e tp r e d i c t i o n ,w ed i d
not observe an effect for miR-34b. Furthermore, we
tested two more inhibitors of miRNAs expressed in
HaCaT cells that are predicted to target TGFBR2:m i R -
93 and miR-423 (miR-20a and miR-93 have the same
seed sequence). The result of the miR-423 assay was not
consistent with expectation, but transfection of the miR-
93 inhibitor resulted in increased TGFBR2 mRNA levels
relative to a LacZ siRNA control (Figure 10B).
In summary, we found evidence of targeting of
TGFBR2 by expressed miRNAs that was consistent with
the siRNA off-target observations, with some evidence
for regional selectivity, that is, regions of the TGFBR2
UTR being particularly sensitive to perturbation by
small RNAs.
Discussion
TGF-b receptors are sensitive to silencing by RNAi
We performed a 6,000-gene siRNA screen for modula-
tors of the TGF-b signal-transduction pathway.
Although the GFP-SMAD2 translocation screen was
indeed effective at isolating modulators of nuclear
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Page 12 of 20localization upon stimulus, it did not succeed in identi-
fying novel components or modulators of the TGF-b
pathway. All screen hits were found to be off-target
effects against TGFBR1 and TGFBR2 (note that siRNAs
intended to target TGFBR1 and TGFBR2 were not
included in the screen, but used as controls), suggesting
that there may be no other non-redundant components
of the SMAD signaling pathway. However, a screen
using a library that covers t h ee n t i r eg e n o m ew o u l d
have to be performed to confirm this theory. Although
the siRNA library was designed to target most known
cancer and cancer-related genes (see Methods), other
lesser-known genes that were not included in this screen
may still be involved in TGF-b signaling.
The off-target hits were the most rate-limiting compo-
nents of the TGF-b pathway, the type I and type II
receptors. Our results recapitulate the outcomes of
experiments conducted more than two decades ago,
when Massagué et al. used an ethyl methanesulfonate
mutagenesis approach to isolate TGF-b-resistant Mv1Lu
mink lung epithelial cells on the basis of growth resis-
tance to the cytostatic action of TGF-b after mutagen-
esis. Analysis of a total of 71 isolated clones showed
that all had mutations that affected either the expression
or protein sequence of TGFBR1 or TGFBR2 [50-55].
However, whereas mutagenesis and selection did not
produce an observable bias towards TGFBR2 compared
with TGFBR1 mutations in the mutagenesis study,
TGFBR2 was the more frequent target for off-target
effects in our screen, by a factor of five (Table 1). Rather
than indicating a more rate-limiting role for TGFBR2 in
the TGF-b pathway, the bias of these observed off-target
effects against TGFBR2 can be interpreted to be due to
the RNAi assay system itself. We considered the possibi-
lity that the observed bias was indicative of increased
susceptibility of TGFBR2 mRNA to siRNA silencing
compared with TGFBR1; however, even though we
attempted to address this question, we did not identify
any significant differences between TGFBR1 and
TGFBR2 mRNA in terms of half-life or abundance (data
not shown). In terms of increased potential for off-target
effects, the 3’ UTR of TGFBR1 might even be consid-
ered a better target, because it is twice as long (almost 5
kb) as the 3’ UTR of TGFBR2.
Interestingly, many siRNAs presented seed matches to
both receptor mRNAs, and resulted in a reduction in
mRNA levels of both receptors. It is unlikely that the
effect of the target genes of these siRNAs on the TGF-b
pathway components is due to upstream regulatory
effects on receptor transcription, as no hit genes were
represented more than once, and several had no evi-
dence of expression in the assay cell type (HaCaT). It is
possible that the effects on the TGF-b receptor mRNAs
are due to off-target effects on upstream regulators of
receptor transcription, but such a gene was not identi-
fied by a global computational analysis of all hit siRNA
sequences and 3’ UTRs of the expressed genome. The
transcriptional regulation of the receptors has been
reported to be dependent on a number of transcription
factors and signal-transduction pathways [56-60], which
complicates this question.
The high rate of off-target effects against the TGF-b
receptors in our screen suggests an increased sensitivity
of the receptors to targeting by RNAi, which raises the
possibility that they are important in vivo miRNA tar-
gets for modulation of cellular sensitivity and response
to TGF-b. TGFBR2 and other genes implicated in neo-
plasia may be targets for regulation by aberrant miRNAs
in cancer [49]. Dysregulation of involved miRNAs can
lead to significant downregulation of the receptors, and
can therefore counteract the growth-suppressing effect
of TGF-b. In addition, as responsiveness to TGF-b is
often lost by cells undergoing neoplastic transformation,
manipulation of such an in vivo mechanism for TGF-b
receptor regulation may be exploited by cells evading
TGF-b cytostatic control or differentiation [24]. For
example, TGFBR2 is potentially suppressed by aberrant
expression of miR-20a in cancer [49] and by induction
of miR-21 during adipogenic differentiation [61]. There
are a number of other miRNAs predicted to target the
3’ UTR regions of the type I and type II TGF-b recep-
tors that are expressed in cancer cell lines [62], includ-
ing miR-373, which is predicted to target TGFBR2 and
has been implicated as an oncogene in testicular germ-
cell tumors [63].
W ef o u n dt h a tt h em R N Al e v e lo fTGFBR2 is modu-
lated by endogenous miRNAs in HaCaT cells. Inhibition,
using an anti-sense inhibitor, of miR-20a or miR-34a,
which are both expressed in HaCaT cells, caused an
increase in TGFBR2 mRNA level, whereas transfection of
miRNA mimics of these siRNAs caused a reduction.
It is possible that endogenousm i R N A sa c ts y n e r g i s t i -
cally with the active siRNAs identified in our screen. As
miRNAs have been shown to behave cooperatively in
their silencing of endogenous transcripts via the 3’ UTR,
there is a possibility that selected siRNA hits mediate
off-target effects by acting cooperatively with endogen-
ous miRNAs regulating TGFBR2 transcripts [64,65]. The
siRNA target regions could indicate proximal miRNA
target areas in the TGFBR2 mRNA, as has recently been
suggested [18]. Based on our results, we speculate that
the susceptibility of the receptor mRNA, especially that
of TGFBR2, is due to cooperativity with an existing
in vivo mechanism for TGFBR2 receptor regulation
through RNAi. The TGF-b receptor transcripts may be
in a ‘primed’ RNAi state due to endogenous miRNA
regulation and RISC association, resulting in constant
association with the RISC.
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NAs may also be an explanation for the higher than
expected number of siRNA hits with silencing activities
against both TGFBR1 and TGFBR2 (based on the num-
ber of siRNAs targeting TGFBR1 or TGFBR2 individu-
ally, the expected number of siRNAs targeting both
receptors is 2 × 10
-5, but the observed number was 2 ×
10
-3). As seen in our siRNA hit list, silencing of only
one of the receptors was sufficient to significantly affect
TGF-b signaling, so selection for double-silencers can-
not be used to explain the results. Certain endogenous
miRNAs could be involved in the regulation of both
TGF-b receptors, and the introduction of siRNAs with
binding sites within an optimal distance from the
miRNA target sites could lead to cooperative activity
between siRNAs and miRNAs. Owing to the very large
number of possible combinations, we were unable to
test this issue experimentally. Combining improved tar-
get prediction and extensive testing of siRNAs and of
miRNA inhibitors may eventually answer this question.
Mechanisms of RNAi off-target effects
Although some degree of off-target effects in our screen
had been anticipated, the magnitude and specificity of
off-target effects found was unexpected. We analyzed
176 individual siRNA sequences in vitro for insight into
the sequence basis of off-target effects against the
TGFBR1 and TGFBR2 mRNAs. Most of the off-target
effects appeared to be mediated by siRNAs containing
seed matches, predominantly in the guide strand, to
conserved regions of the 3’ UTR of the mRNAs
transcripts.
Our analysis identified a number of characteristics that
appear to be similar to those described for miRNA tar-
geting. The siRNA hit population displayed significant
enrichment for miRNA-like traits, such as a heptamer
seed match, t1A anchors, t9W, G:U wobbles in the seed
region, 3’ sequence matches, and positional bias along
the 3’ UTR regions and conserved regions. One para-
meter that emerged as a result of our analysis was a
match at position 16 of the siRNA, which seemed to be
one of the most highly enriched among the siRNA hits,
both in our dataset and in siRNA datasets reported pre-
viously [20,22].
The importance of position 16 for siRNA targeting has
been noted previously [22], but has not yet been
described in the context of siRNA off-target effects.
Recent structural work revealed that the mechanism of
siRNA target binding most likely involves the release of
the 3’ end of the siRNA from the Paz domain [66]. In
this way, the 5’ end of the siRNA remains tethered
inside the mid domain of the Argonaute protein, and
there is a helical conformation of positions 12-15, allow-
ing catalytic residues in Argonaute to be placed
optimally in relation to the target mRNA. Detailed trun-
cation experiments showed that the release of the 3’ end
of the guide siRNA from the PAZ domain is driven by
residue matching up to position 16 [66]. Interestingly,
this release from the PAZ domain confirmed earlier bio-
chemical work by the Zamore group, who first sug-
gested the ‘two-state model’ [67]. Other systematic
analyses have also shown a role for position 16 in the
efficacy of siRNA [68], and position 16 was one of only
five positions at which mutations showed effective dis-
crimination against the wild-type SOD1 reporter [22].
We also observed an enrichment of seed matches con-
taining G:U wobbles. Surprisingly, these G:U wobble
pairs occurred preferentially at certain positions of the
s i R N A ,w i t hap r e f e r e n c ef o raGa ts i R N Ap o s i t i o n s3
and 8, and U at positions 2 and 4.
In our study, we also found a number of siRNA hits
that had no seed matches to either the 3’ UTR or the
ORF regions of the receptors. When we tested the
siRNA hits without seed matches to the 3’ UTR of the
receptors, we found they also resulted in a reduction in
mRNA levels of the TGF-b receptors and in silencing
against the 3’ UTR regions in a luciferase assay.
All our data indicate the importance of a perfect seed
match, but although a seed match is a strong predictor
for siRNA silencing, it is by no means essential. Existing
seed-match based miRNA target prediction methods,
such as TargetScan, have included parameters in addition
to the seed, such as binding of the 3’ end of the miRNA,
local A:U content, target structure and conservation, all
of which result in increased prediction specificity. How-
ever, each increase in specificity is accompanied by a sig-
nificant decrease in sensitivity. A balanced weighting of
these features can help, but ultimately, the strict require-
ment of a seed match limits this method. Each additional
component of the miRNA mechanism identified should
allow relaxation of the strict requirement for a seed
match. For example, miRNA-target relationships with
mismatches and G:U wobbles in the seed region have
been identified, and it has been hypothesized that a sig-
nificant part of this specificity may depend on the mRNA
sequence or secondary structure. In addition, the number
of siRNA target sites in a particular sequence can also
increase silencing efficacy.
One striking observation in our analysis is that exist-
ing seed-based methods drastically overpredict the num-
ber of siRNA target sites. In our example, only 61 of
>3000 siRNA sequences with at least one heptamer seed
match against the 3’ UTR of TGFBR2 had the ability to
downregulate TGFBR2.
Improving future RNAi screens
The extent of the off-target effects seen in our study
may be specific to the assay and siRNA library we used.
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should be taken in interpreting results from siRNA
screens. We join other groups who call for some vigi-
lance when using large- or small-scale RNAi techniques
[23,69]. A strict requirement for multiple potent siRNAs
against one gene may reduce the likelihood of overinter-
preting screen hits resulting from off-target effects [70].
In addition, any presumed biological effect due to tar-
get-specific knockdown ideally should be verified by
observing its reversal after reintroducing the particular
gene product in knockdown experiments.
There is an ongoing need for further improvement in
siRNA design. Our results suggest that avoiding G and
U nucleotides in the seed region during siRNA design
could reduce off-target effects to some extent, and there
may be other position-specific preferences that could be
exploited. Chemical modification of certain siRNA posi-
tions has recently been shown to reduce off-target
effects [71]. Other RNAi methods with less potential for
off-target effects, such as endoribonuclease-prepared
siRNAs, may be more appropriate for large-scale screens
of signal-transduction pathways [72], although they pre-
sent novel challenges, such as the potential induction of
interferon response in certain cell types [73].
Furthermore, saturation of the miRNA machinery by
transfection of siRNAs and the subsequent release of
miRNA inhibition of other endogenous genes can have
unintended consequences [74], but simply lowering
siRNA concentrations will compromise targeting effi-
ciency. mRNA-specific features such as mRNA half-life
should also be taken into account [75]. If all these chal-
lenges can be overcome, miRNAs, siRNAs or their ana-
logues may have even greater potential in therapeutics.
Methods
siRNA library
The siRNA library used (synthesized at Memorial Sloan-
Kettering Cancer Center (MSKCC) by the Organic
Synthesis Core Facility) encompasses ~21,000 RNA
duplexes targeting approximately 6,000 human genes,
and each gene is targeted by an average of three inde-
pendent siRNAs (see Additional File 2 Table S1). The
library was designed to cover most known genes or
genes with suspected function, with a bias toward can-
cer biology, including all genes reported to be causally
related or even correlated with cancer in vivo or trans-
formation in vitro. In addition, all known kinases, phos-
phatases, cell-surface receptors and signal-transduction
components were represented.
Library design was based on rules by Reynolds et al.
[36] and were further refined through quantitative ana-
lysis of suppression of two test proteins (Lack and Rab-
6), using an extensive array of sequences (more than
500 individual siRNAs) derived from these genes [17].
These newly derived rules represent a compromise
between siRNA efficacy (0.74 probability of >70%
knockdown of protein per siRNA, and a 0.98 probability
that one out of three siRNAs will work) and the ability
to find such a sequence in a particular gene. In those
few cases where a sequence could not be found, the
rules were relaxed, with a reduction in probability (for
three siRNAs) to 0.91. The design rules for the siRNAs
were as follows (defined for the siRNA guide strand): 1)
A or U at position 1 and 9, and/or G or C at position
19 (the position 1 A or U has priority); 2) three or more
A or U nucleotides at positions 1 to 7; 3) no single-
nucleotide polymorphisms; 4) location at least 100
nucleotides from a start or stop codon; 5) uniqueness of
the sequence verified by BLAST analysis; and 6) selec-
tion of shared sequences for genes with multiple tran-
scripts. A summary of the library composition is
included (see Additional File 3 Table S7). All sequences
were 19-mers with an additional dTdT 3’ overhang. All
RNA molecules were purified by high-performance
liquid chromatography.
Screen
The screen was performed (MSKCC High-Throughput
Screening Facility) in 384-well plates with a plating den-
sity of 3,000 cells per well. Cells were transfected with
siRNA the day after plating, and then stimulated with
100 pmol/l TGF-b-1 48 hours after transfection. Cells
were stained with Hoechst stain, and fixed 90 minutes
after stimulation.
Confocal images (one frame per well) were acquired
(IN Cell Analyzer 3000; GE Healthcare, Waukesha, WI,
USA). Nuclear translocation data were extracted using
the nuclear-trafficking analysis module, and cell size and
GFP intensity ranges were selected to achieve maximum
separation between positive and negative controls,
resulting in an average Z’ score of 0.5. Images of all
screen hits were inspected visually, and hits resulting
from poorly aligned images (GFP versus nuclear-staining
channel) or poor cell morphology were flagged and
excluded from downstream analyses. Selected represen-
tative images are available at http://cbio.mskcc.org/tgf-
beta_screen/.
Normalization of screen results
Initial analysis of the raw data revealed experimental bias,
as elevated N:C ratios were found along the edges of all
plates relative to the ratios in control wells located in the
middle of each plate. Further analysis showed that this
effect was dependent on cell density; that is, N:C ratios
were inversely correlated with the number of cells
imaged per well (see Additional File 1 Figure S1). The
lower cell density in the outside wells was most likely due
to uneven settling of the cells, as cells tend to migrate to
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would lead to an increased cell density towards the outer
edges of the outside wells and a decrease in the center of
the wells, which was the area from which all our images
were acquired. To correct for this effect, we developed a
linear regression method to normalize N:C ratios by the
cell number assayed per well.
First, individual plate baseline and variability effects
were corrected for by standardizing each plate to a
mean of 0 and SD of 1. To avoid confounding effects,
where N:C outliers were generated by aberrant cell
count or plate position, N:C ratios were corrected with
respect to both cell count and plate position. The cor-
rection was performed in Matlab as follows (code avail-
able on request). For each well, a linear bias function
was estimated, which describes how cell count affects
the N:C ratio in that region of the plate, using the linear
equation
BIAS(plate,well) =A (well) +B (well) × N(plate,well),
where N is the cell count, and A and B are coeffi-
cients. The coefficients A and B were fitted using linear
least squares, in a robust procedure that took into
account information from neighboring wells (nearest
neighbor kernel estimation). Wells with measurements
for <400 cells were removed from the analysis. Having
estimated A and B, corrected N:C ratios were obtained
by subtracting the bias term. In a final correction step,
corrected N:C values were standardized to s = 1 across
the 65 plates.
Cell lines and transfection
HaCaT keratinocytes were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal
bovine serum. The cell-culture medium also contained
100 U/ml penicillin and 100g/ml streptomycin, 2 mmol/
l L-glutamine and 1 ug/ml fungizone. Transient trans-
fection of siRNA ribonucleotide oligomers and siRNA/
DNA co-transfections were performed using a commer-
cial reagent (Lipofectamine 2000, Invitrogen, Carlsbad,
CA, USA), in accordance with the manufacturer’s
instructions, as was transfection of DNA into HaCaT
cells (Lipofectamine, Invitrogen).
Generation of the GFP-SMAD2 cell line
The coding sequence for SMAD2 was amplified by PCR
from human cDNA and inserted into a cloning vector
(Zero Blunt 2.0, Invitrogen). Enhanced (E)GFP was
amplified by PCR from an EGFP plasmid (Clontech,
Mountain View, CA, USA), using modified primers that
contained a KpnIa n daXhoI restriction site in the 5’
region of the forward primer, and a KpnIs i t ei nt h e5 ’
region of the reverse primer. EGFP was subsequently
cloned into the KpnIs i t eo ft h eS M A D 2Z e r oB l u n t
plasmid, and the EGFP-SMAD2 fusion sequence was
then cloned into the XhoI site of the mammalian
expression plasmid pCAGGS.
To generate the stable EGFP-SMAD2 cell line, the
EGFP-SMAD2 expression plasmid was transfected into
HaCaT keratinocytes. After 2 weeks of culture, cells
were subjected to fluorescence-activated cell sorting
(FACS) to isolate stably transfected EGFP-positive cells
(~0.5%). These cells were then grown up and subjected
to another round of sorting, in which only cells with
moderate EGFP levels were selected.
Generation of luciferase reporter constructs
The coding sequence for firefly luciferase was cloned
into the KpnIa n dMluI sites of the mammalian expres-
sion vector pCMV5 to generate constitutive luciferase
expression. The PCR-amplified 3’ UTR (NM_001024847,
nucleotides 2108-4680) or ORF (NM_001024847,
nucleotides 383-2161) regions of TGFBR2 were inserted
immediately downstream of the firefly luciferase stop
codon.
Luciferase assays
Luciferase assays in SW13 cells with a mammalian TGF-
b-inducible luciferase reporter construct (SBE-4X) [77]
were performed as described previously [78]. A constitu-
tively active cytomegalovirus-Renilla luciferase plasmid
(Promega, Madison, WI, USA) was included as an inter-
nal control. For 3’ UTR and control reporter assays, 50
ng each of reporter plasmid were transfected with 60
pmol siRNA per well in 12-well plates, with each trans-
fection performed in triplicate. Luciferase activity in
these assays was evaluated 24 hours after transfection.
miRNA mimics and miRNA inhibitors
miRNA mimic duplexes were synthesized and annealed
(Sigma Proligo, St. Louis, MO, USA) with the sequences
shown in Table 2 (from Sanger miRBase release 9.2).
miRNA inhibitors were obtained from a commercial
source (anti-miR; (Ambion, Austin, TX, USA). miRNA
mimic duplexes and miRNA inhibitors were transfected
using the same protocol and amounts as the siRNA
duplexes described above.
Table 2 Sequences used for generation of microRNAs
miR-20a UAAAGUGCUUAUAGUGCAGGUAG
miR-20a* ACUGCAUUAUGAGCACUUAAAGU
miR-34b UAGGCAGUGUCAUUAGCUGAUUG
miR-34b* AUCACUAACUCCACUGCCAUCA
miR-373 GAAGUGCUUCGAUUUUGGGGUGU
miR-373* ACUCAAAAUGGGGGCGCUUUCC
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We used antibodies recognizing phospho-tail SMAD2
Ser-465/467 (Cell Signaling, Danvers, MA, USA) and
murine antibodies against a-tubulin (Sigma-Aldrich, St.
Louis, MO, USA). The SMAD2 antibody (183 to 273
peptides) has been described previously [79]. For immu-
nofluorescence experiments, HaCaT cells were plated on
chamber slides (LabTek II; Nunc, Rochester, NY, USA)
and treated with 100 pmol/l TGF-b-1 for 60 minutes.
Cells were fixed in 4% paraformaldehyde. Alexa Fluor
488-conjugated goat anti-rabbit IgG (Invitrogen) was
used as a secondary antibody.
Quantification of mRNA by real-time PCR analysis
Total RNA from HaCaT cells was harvested (RNeasy Kit;
Qiagen, Valencia, CA, USA). cDNA was synthesized
from 100 ng of purified RNA (High-Capacity cDNA
Archive Kit for RT-PCR; Applied Biosystems, Foster City,
CA, USA) in accordance with the manufacturer’sp r o t o -
col. Quantitative reverse transcriptase PCR was per-
formed in an automated PCR system (7900HT; Applied
Biosystems). All reactions were performed in a volume of
10 μl containing cDNA template equivalent to 500 pg of
RNA template, 0.1 μmol/l primers (Table 3) and 5 μlo f
2× SYBR Green I Master Mix (Applied Biosystems). Each
sample was analyzed in quadruplicate. PCR cycling para-
meters were: 50°C for 2 minutes and 95°C for 10 minutes,
then 40 cycles of 94°C for 15 seconds and 60°C for 1
minute. Data analysis was performed using the compara-
tive Ct method (SDS, version 2.2.2; Applied Biosystems).
Hypoxanthine phosphoribosyltransferase (HPRT) 1 and
SMAD4 were used for normalization.
Quantification of mRNA by branched DNA assay
HaCaT cells were transiently transfected with siRNA in
12-well plates. Cells were harvested 48 hours after
transfection and processed (QuantiGene Reagent System;
Panomics, Fremont, CA, USA) in accordance with manu-
facturer’s instructions. Cells were lysed in a volume of 1.5
ml, and 30 ml of lysate probed in duplicate with the fol-
lowing QuantiGene probe sets: human TGFBR1-PA-
10418-02, human TGFBR2-PA-10587-02 and human
HPRT1-PA-10389-02 (used for normalization).
Quantification of miRNAs by real-time PCR analysis and
by microarray
RNA was isolated (mirVana™ miRNA Isolation Kit;
Ambion). Quantitative PCR analysis of selected miRNAs
in HaCaT cells was performed (TaqMan miRNA Assays;
Applied Biosystems) in accordance with the manufac-
turer’s instructions. In parallel, miRNA profiles of
HaCaT cells were generated( H u m a nm i R N AM i c r o a r -
ray Kit, version 1; Agilent, Santa Clara, CA, USA).
3’ UTR sequence analysis
RefSeq sequences NM_001130916 and NM_001024847
were used for sequence analysis of TGFBR1 and
TGFBR2, respectively. Ensembl version 58 (143,127 3’
UTRs) was used for the identification of the most fre-
quent off-target genes.
Additional material
Additional file 1: Supplementary Figures. Figure S1. Effect of cell
number on nuclear:cytosolic (N:C) ratio and normalization.
Correlation between cell number and N:C ratio (left) before and (right)
after normalization. Figure S2. Chemical inhibitors against protein
kinase A and A-kinase anchor protein (AKAP), two candidate hits
in this screen, had no effect on transforming growth factor (TGF)-
b-induced expression of SMAD7. Two inhibitors of protein kinase A
(14-22 and H89), an inhibitor against AKAP (Ht31) and a TGFBR2
inhibitor (SB431542) were tested on HaCaT cells exposed to different
concentrations of TGF-b. SMAD7 induction was inhibited only in the
presence of the TGFBR2 inhibitor. Error bars on each column are the
mean ± SD of three experiments. Figure S3. Small interfering (si)
RNA hits but not other siRNAs designed for the same target
silenced a TGFBR2 3’ UTR luciferase construct. siRNAs designed to
target the same genes as those identified as hits in the screen were
tested for their effect in silencing a TGFBR2 3’ UTR luciferase construct.
The screen hit caused significant silencing of the luciferase, whereas
the other matched siRNA did not. The control siRNA for A-kinase
anchor protein (AKAP) P13 (Ambion) was not used in the screen. The
data are presented (y-axis) as the relative repression of firefly luciferase
expression standardized to Renilla luciferase as a transfection control.
Integers (for example 9, 18) label ranked siRNA hits. Error bars on each
column are the mean ± SD of three experiments. Figure S4. Screen
hits with a verified effect on TGFBR2 were enriched for small
interfering (si)RNA seed matches to the TGFBR2 ORF.S c r e e nh i t s
with measured effects on TGFBR2 (n = 106) were found to be slightly
enriched for heptamer seed matches to the ORF of TGFBR2 compared
with the non-hit control group (r = 1.37). This enrichment was
significantly higher after removing all siRNA sequences with one or
more heptamer seed matches to the TGFBR2 3’ UTR (r =2 . 0 3 ,P =
0.0046, Fisher’s exact test).
Additional file 2: Supplementary Tables 1-3. Table S1: Full screen
results, Table S2: Target gene analysis (siRNA knockdown efficiencies),
Table S3: Detailed analysis of 193 screen hits
Table 3 Primers used for quantitative PCR analysis
CDKN1A-fw CCGAGGCACTCAGAGGAG
CDKN1A-rev AGCTGCTCGCTGTCCACT
SERPINE1-fw AAGGCACCTCTGAGAACTTCA
SERPINE1-rev CCCAGGACTAGGCAGGTG
HPRT1-fw TGACCTTGATTTATTTTGCATACC
HPRT1-rev CGAGCAAGACGTTCAGTCCT
SMAD4-fw CCTGTTCACAATGAGCTTGC
SMAD4-rev GCAATGGAACACCAATACTCAG
SMAD7-fw AGGGGGAACGAATTATCTGG
SMAD7-rev ACCACGCACCAGTGTGAC
TGFBR1-fw TGTTACGTCATGAAAACATCCTG
TGFBR1-rev ACCAGAGCTGAGTCCAAGTACC
TGFBR2-fw GACCAGAAATTCCCAGCTTCT
TGFBR2-rev CAACGTCTCACACACCATCTG
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Page 17 of 20Additional file 3: Supplementary Tables 4-7. Table S4: TGFBR2 is the
most significantly off-targeted gene (guide strand). Table S5: TGFBR2 is
among the most off-targeted gene (passenger strand). Table S6: TGFBR2
is the only significantly off-targeted gene (both strands). Table S7: siRNA
library composition (guide strand).
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